Blog
Walmart Looks Strong Ahead of Q1 Earnings: Should Investors Stay Put?
Walmart Inc. WMT heads into its first-quarter fiscal 2027 earnings release on a strong footing, supported by sustained momentum in its omnichannel operations, growing digital ecosystem and resilient
GSL to Report Q1 Earnings: What's in Store for the Stock?
Global Ship Lease GSL is scheduled to report first-quarter 2026 results on May 22, before the market opens.
The Zacks Consensus Estimate for GSL’s first-quarter 2026 earnings per share has remained
Amazon Refreshes Fire TV, Alexa+: Can Retail Tailwind Lift the Stock?
Amazon AMZN is pressing its devices ecosystem into service as a retail conversion engine, with a string of Fire TV and Alexa+ updates rolled out across April and May 2026 designed to translate
ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer
ImmunityBio IBRX announced that it has received five patents in the United States covering the combination of its sole marketed drug, Anktiva, with Bacillus Calmette-Guérin (BCG) for the treatment
Housing Data Enters the Chat: NAHB, HD, TOL
Tuesday, May 19th, 2026Pre-market futures are off their early-morning lows, but still trading lower than Monday’s close. We’re already riding the worst two-session streak for tech stocks (Nasdaq and
CALY's Margin Initiatives Gain Traction: Is This Just the Beginning?
Callaway Golf Company CALY delivered an encouraging start to 2026 as its ongoing margin improvement efforts began translating into stronger profitability and cash generation.
The company reported
Are High Oil Prices a Key Driver of SM's Energy Operations?
The price of West Texas Intermediate (“WTI”) crude is trading at more than the $100-per-barrel mark. The high price is being driven by the Iran-war shock. The U.S. Energy Information Administration
Kulicke & Soffa Rides on Multiple Growth Drivers: Should You Invest?
Kulicke & Soffa Industries Inc. KLIC is well-positioned to benefit from several favorable secular trends across the semiconductor industry. The company continues to gain from rising demand for
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
Bayer BAYRY announced that the FDA has accepted its new drug application (NDA) for its investigational, once-daily, oral Factor XIa inhibitor, asundexian, for preventing ischemic stroke in patients
Can Recovery in Farnell Accelerate Avnet's Margin Expansion?
Avnet Inc. AVT is seeing steady improvement in its Farnell business, which is driving the company's overall profitability. Revenues from the Farnell segment increased 24% on a year-over-year basis
SiTime Benefits From Holistic Growth Initiatives: Reason to Buy?
SiTime Corporation SITM is benefiting from strong execution across both organic and inorganic growth drivers, positioning it well for sustained long-term expansion in the rapidly evolving
Best Momentum Stocks to Buy for May 19th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 19:
Vishay Intertechnology, Inc. VSH: This semiconductor company has a Zacks Rank #1 and
5 Reasons to Add Prologis Stock to Your Portfolio Right Now
Prologis, Inc. PLD remains a scaled owner of infill logistics facilities that are central to modern distribution networks. Development, disciplined capital recycling and new strategic capital
3 Reasons ServiceNow (NOW) is Soaring
Although the market has been volatile this week, ServiceNow shares are on a tear. Below are three reasons why:
Bank of America Upgrade Boosts NOW
ServiceNow (NOW) is a software-as-a-service
Implied Volatility Surging for Brink's Stock Options
Investors in The Brink’s Company BCO need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $70.00 Call had some of the highest
PDD Holdings Inc. Sponsored ADR (PDD) to Report Q1 Results: Wall Street Expects Earnings Growth
The market expects PDD Holdings Inc. Sponsored ADR (PDD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This
Seanergy Maritime Holdings Corp (SHIP) to Report Q1 Results: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Seanergy Maritime Holdings Corp (SHIP) reports results for the quarter ended March 2026. While this widely-known
Oil Slides as Trump Delays Planned Strike on Iran: ETFs to Win
Oil prices moved lower Tuesday after U.S. President Donald Trump said he had postponed a planned military strike on Iran, easing concerns over a potential escalation that could disrupt global crude
Stagflation Risks Brewing? ETFs to Play
The EU will cut its growth forecast and raise inflation projections due to the “stagflationary shock” triggered by the Iran war, European economy commissioner Valdis Dombrovskis told CNBC.
Speaking
Intuit Expands QuickBooks With AI: Will It Accelerate Growth?
Intuit Inc.’s INTU QuickBooks is an accounting software platform designed to help businesses manage their finances in one place. It is commonly used for tracking income and expenses, creating
Wall Street Analysts See a 29.58% Upside in Allegro MicroSystems (ALGM): Can the Stock Really Move This High?
Shares of Allegro MicroSystems, Inc. (ALGM) have gained 1.7% over the past four weeks to close the last trading session at $41.35, but there could still be a solid upside left in the stock if
Wall Street Analysts Think Figure Technology (FIGR) Could Surge 38.67%: Read This Before Placing a Bet
Figure Technology (FIGR) closed the last trading session at $38.58, gaining 6.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe Corcept (CORT) Could Rally 43.32%: Here's is How to Trade
Corcept Therapeutics (CORT) closed the last trading session at $55.12, gaining 19% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade
Candel Therapeutics, Inc. (CADL) closed the last trading session at $7.9, gaining 9.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set



